Found: 40
Select item for more details and to access through your institution.
Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41952-w
- By:
- Publication type:
- Article
Differential Efficacy of Targeted Monoclonal Antibodies in Left-Sided Colon and Rectal Metastatic Cancers.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 3, p. 298, doi. 10.1016/j.clcc.2023.05.002
- By:
- Publication type:
- Article
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dramatic Response in a Patient with Metastatic Gastric Cancer Using Trifluridine/Tipiracil after Rapid Disease Progression while on Nivolumab.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 3, p. 1381, doi. 10.1159/000510405
- By:
- Publication type:
- Article
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 6, p. 1032, doi. 10.1038/s41416-023-02378-9
- By:
- Publication type:
- Article
A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 6, p. 1050, doi. 10.1007/s10120-018-0825-y
- By:
- Publication type:
- Article
Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2017, v. 93, n. 5, p. 329, doi. 10.1159/000479280
- By:
- Publication type:
- Article
Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody.
- Published in:
- Oncology, 2017, v. 92, n. 4, p. 205, doi. 10.1159/000453336
- By:
- Publication type:
- Article
Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer.
- Published in:
- Oncology Letters, 2017, v. 14, n. 2, p. 2545, doi. 10.3892/ol.2017.6409
- By:
- Publication type:
- Article
A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study.
- Published in:
- Ecancermedicalscience, 2018, v. 12, n. 844-874, p. 1, doi. 10.3332/ecancer.2018.847
- By:
- Publication type:
- Article
Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 764, doi. 10.1007/s10147-024-02508-0
- By:
- Publication type:
- Article
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 6, p. 756, doi. 10.1007/s10147-023-02330-0
- By:
- Publication type:
- Article
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 644, doi. 10.1007/s10147-023-02316-y
- By:
- Publication type:
- Article
A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 4, p. 701, doi. 10.1007/s10147-020-01842-3
- By:
- Publication type:
- Article
Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 5, p. 890, doi. 10.1007/s10147-016-0963-3
- By:
- Publication type:
- Article
Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 755, doi. 10.1007/s10147-014-0772-5
- By:
- Publication type:
- Article
Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment.
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 4, p. 656, doi. 10.1007/s10147-013-0610-1
- By:
- Publication type:
- Article
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1123, doi. 10.1007/s00432-022-03979-2
- By:
- Publication type:
- Article
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.
- Published in:
- Oncologist, 2023, v. 28, n. 11, p. e1108, doi. 10.1093/oncolo/oyad143
- By:
- Publication type:
- Article
Phase I Study of Alternate‐Day Administration of S‐1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1614, doi. 10.1634/theoncologist.2020-0463
- By:
- Publication type:
- Article
A Prospective Trial Evaluating the Safety of a Shortened Infusion of Ramucirumab in Patients with Gastrointestinal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 159, doi. 10.1634/theoncologist.2018-0580
- By:
- Publication type:
- Article
Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 1, p. 50, doi. 10.1002/ccr3.3399
- By:
- Publication type:
- Article
Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 1, p. 394, doi. 10.1002/cam4.2688
- By:
- Publication type:
- Article
The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835918820298
- By:
- Publication type:
- Article
The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835918820298
- By:
- Publication type:
- Article
A phase II trial of prophylactic olanzapine combined with palonosetron and dexamethasone for preventing nausea and vomiting induced by cisplatin.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 3, p. 254, doi. 10.1111/ajco.12489
- By:
- Publication type:
- Article
Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study.
- Published in:
- Journal of Gastric Cancer, 2023, v. 23, n. 2, p. 289, doi. 10.5230/jgc.2023.23.e15
- By:
- Publication type:
- Article
A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 3, p. 228, doi. 10.1093/jjco/hyv193
- By:
- Publication type:
- Article
A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1606-1
- By:
- Publication type:
- Article
A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 601, doi. 10.1186/s12885-015-1606-1
- By:
- Publication type:
- Article
A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 357, doi. 10.1007/s00280-015-2806-8
- By:
- Publication type:
- Article
CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 2, p. 409, doi. 10.1007/s00280-013-2367-7
- By:
- Publication type:
- Article
Updated Immunotherapy for Gastric Cancer.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 7, p. 2636, doi. 10.3390/jcm12072636
- By:
- Publication type:
- Article
Chronological improvement of survival in patients with advanced gastric cancer over 15 years.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241229428
- By:
- Publication type:
- Article
A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 3, p. 369, doi. 10.1007/s11523-023-00963-9
- By:
- Publication type:
- Article